Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Open-market buy CEO & Chairman bought 15,000 shares at $2.80 ($42,000)
  2. 4 Open-market buy COO & President bought 10,000 shares at $2.85 ($28,500)
  3. 4 Open-market sale Director sold 43,215 shares at an average $3.12 ($134,793)
  4. 4 Open-market sale Director sold 67,858 shares at $4.02 ($272,789)
  5. 4 Open-market sale Director sold 45,000 shares at $4.00 ($180,000)
  6. 4 Open-market sale Director sold 35,000 shares at $4.02 ($140,840)
  7. 4 Grant or award CFO acquired 27,500 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 12,500 shares at an average $4.51 ($56,402)
  10. 4 Open-market sale Director sold 35,625 shares at an average $4.51 ($160,736)
  11. 4 Open-market sale CEO & Chairman sold 69,850 shares at an average $4.29 ($299,984)
  12. 4 Open-market sale CFO, Executive Vice President sold 69,850 shares at an average $4.29 ($299,984)
  13. 4 Open-market sale Director sold 26,453 shares at an average $4.29 ($113,546)
  14. 4 Open-market sale CFO, Executive Vice President sold 30,150 shares at $4.25 ($128,138)
  15. 4 Open-market sale CEO & Chairman sold 30,150 shares at $4.25 ($128,138)
  16. 4 Open-market sale Director sold 44,797 shares at an average $4.12 ($184,687)
  17. 4 Grant or award CEO & Chairman acquired 150,000 shares (grant or award)
  18. 4 Grant or award CFO, Executive Vice President acquired 150,000 shares (grant or award)
  19. 4 Grant or award Director acquired 50,000 shares (grant or award)
  20. 4 Grant or award Director acquired 35,000 shares (grant or award)

Page 9 of 18 · 352 filings